ReviewInsights into imaging2022
Radiology-pathology correlation of endometrial carcinoma assessment on magnetic resonance imaging.
Review in Insights into imaging, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Article
- Comparison of three-tesla magnetic resonance imaging with pathology in detecting deep myometrial invasion in endometrial cancer and revealing causes of discrepancy.Diagnostic and interventional radiology (Ankara, Turkey) · 2026Article
- Pictorial review of bilateral adnexal lesions.Abdominal radiology (New York) · 2025Review
- Exploratory Analysis of Radiomics and Pathomics in Uterine Corpus Endometrial Carcinoma.Scientific reports · 2024Article
- Evaluation of multi-parameter MRI in preoperative staging of endometrial carcinoma.European journal of radiology open · 2024Article
- The volumetric ADC histogram analysis in differentiating stage IA endometrial carcinoma from endometrial polyp.The British journal of radiology · 2024Article
- Endometrial Cancer Staging: Is There Value in ADC?Journal of personalized medicine · 2023Article
- Diagnostic value of the apparent diffusion coefficient in differentiating malignant from benign endometrial lesions.Frontiers in oncology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Endometrial carcinoma is the most common gynaecological cancer in developed countries. Most cases are low-volume/low-grade tumour at presentation; however, high-grade subtypes may present with locally advanced disease with higher propensity for spread outside of the pelvis. MRI has a role in local staging of the tumour and helping the clinicians in treatment decision making. This pictorial essay gives examples of endometrial carcinoma at different stages with histological correlation. It also explores the potential limitations and pitfalls of imaging in this context.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.